The University of Colorado Cancer Center is a """"""""Center"""""""" within the organizational structure of the School of Medicine at the University of Colorado Health Sciences Center campus. The major goals of the Cancer Center are: 1) to contribute through a coordinated research, clinical treatement, control, and educational effort to the eventual elimination of cancer as a human health problem; and 2) to provide the citizens of the State of Colorado and the Rocky Mountain Region with state-of-the-art cancer therapy, research, control and educational programs. The Rocky Mountain Region and its approximate 5 million inhabitants is the largest region of the U.S. not served by an NCI funded Cancer Center. The members of the University of Colorado Cancer Center currently have more than $18 million in outside grant and contract support, and provide the major clinical care for over 30% of the cancer patients in this region. We provide the primary access to clinical studies for patients in this region. As our cancer efforts have intensified over the past 2-3 years our needs for interdisciplinary coordination, space, and new personnel have increased markedly. The support of this core support grant and institutional support should aid us in establishing a true center of excellence in cancer. The Cancer Center has 4 major program areas; basic research, clinical activities, cancer control activities, and educational activities each with an Associate Director. The Basic Science and Clinical Programs are subdivided into smaller program areas. These include Immunology, Molecular Biology, Hormones, Growth Regulation, Cell Surface, and Chromosomes for the Basic Science Program and Medical, Surgical, Radiation, Pediatric and Nursing Oncology for the Clinical Program. The primary planning and management decisions are made by the Management Committee which consists of the Director, Associate Directors and Program Leaders. There are 9 shared core facilities which provide support for the research efforts of Center members. The Center has a number of affiliated Schools, Hospitals and Institutes who are represented on the Cancer Center Board, an Advisory Board which reports to the Dean and Director. This Board assures the coordination of all the institutions in the region which are committed to the control of the cancer problem. Thus, the University of Colorado Cancer Center provides the leadership for the interdisciplinary study of cancer in the Rocky Mountain Region.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046934-02
Application #
3101848
Study Section
Cancer Center Support Grant Review Committee (CCS)
Project Start
1988-03-01
Project End
1991-02-28
Budget Start
1989-03-01
Budget End
1990-02-28
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Pei, Shanshan; Minhajuddin, Mohammad; Adane, Biniam et al. (2018) AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells. Cell Stem Cell 23:86-100.e6
Ren, Shengxiang; Rivard, Christopher J; Yu, Hui et al. (2018) A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines. Clin Lung Cancer 19:450-456
Donson, Andrew M; Amani, Vladimir; Warner, Elliot A et al. (2018) Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma. Mol Cancer Ther 17:1984-1994
Branchford, B R; Stalker, T J; Law, L et al. (2018) The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis. J Thromb Haemost 16:352-363
Wahdan-Alaswad, R S; Edgerton, S M; Salem, H S et al. (2018) Metformin Targets Glucose Metabolism in Triple Negative Breast Cancer. J Oncol Transl Res 4:
Ryan, Weston Kenneth; Fernandez, Josiah; Peterson, Mikayla Katherine et al. (2018) Activation of S6 signaling is associated with cell survival and multinucleation in hyperplastic skin after epidermal loss of AURORA-A Kinase. Cell Death Differ :
Monks, Jenifer; Orlicky, David J; Stefanski, Adrianne L et al. (2018) Maternal obesity during lactation may protect offspring from high fat diet-induced metabolic dysfunction. Nutr Diabetes 8:18
Garcia, Tamara B; Fosmire, Susan P; Porter, Christopher C (2018) Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine. Leuk Res 64:30-33
Helfrich, Barbara A; Gao, Dexiang; Bunn Jr, Paul A (2018) Eribulin inhibits the growth of small cell lung cancer cell lines alone and with radiotherapy. Lung Cancer 118:148-154
Oweida, Ayman; Phan, Andy; Vancourt, Benjamin et al. (2018) Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic Thyroid Cancer. Thyroid 28:739-747

Showing the most recent 10 out of 1634 publications